News

In the Phase IIIB APPULSE-PNH study, adult patients with paroxysmal nocturnal hemoglobinuria (PNH) who switched to Fabhalta experienced clinically meaningful improvements in hemoglobin (Hb) levels of ...
Among the 7MM, Japan accounts for the second highest total aplastic anemia drugs market. The Aplastic Anemia Treatment Market ...
India could take a leaf out of the Mahbubnagar district model, where 100 percent screening is done to keep a check on ...
The VERIFY trial explores rusfertide to manage polycythemia vera without causing iron deficiency symptoms, Dr. Aaron Gerds explained.
Last Thursday during a roundtable on stem cell therapies, new FDA Commissioner Marty Makary referred to EBM levels of evidence as an artificial and dogmatic construct. Apparently Dr. David Katz's "mor ...
Background Current treatments with tyrosine kinase inhibitors and immune checkpoint inhibitors have limited efficacy for ...
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today positive results from the Phase III IMforte study of Tecentriq® (atezolizumab) in combination with lurbinectedin ...
The monumental achievement, in collaboration with Ernest McCulloch, opened the door to regenerative medicine and its ...
Should thalassemia carriers marry? Can thalassemia be prevented? Doctor shares information about this blood disorder that ...
CRANBURY, NJ, USA I May 27, 2025 I Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing an integrated ...
Red light therapy uses a broad range of light to cover larger ... Stem cells are extracted from bone marrow or fat tissue then processed in a laboratory and injected into the afflicted joint. While ...
The Boston Red Sox recently had to make a change in the infield. Boston lost first baseman Triston Casas to a serious knee injury and it seems likely at this moment that he's not going to be back ...